Innate immunity in lung transplantation

Copyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved..

Innate immune pathways early after pulmonary transplantation have been shown to cause primary graft dysfunction (PGD) and also predispose to late graft failure. Recent studies in animal models have elucidated critical mechanisms governing such innate immune responses. Here, we discuss pathways of inflammatory cell death, triggers for sterile and infectious inflammation, and signaling cascades that mediate lung injury early after transplantation. These studies highlight potential avenues for lung-specific therapies early following lung transplantation to dampen innate immune responses and improve outcomes.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation - 40(2021), 7 vom: 18. Juli, Seite 562-568

Sprache:

Englisch

Beteiligte Personen:

Shepherd, Hailey M [VerfasserIn]
Gauthier, Jason M [VerfasserIn]
Li, Wenjun [VerfasserIn]
Krupnick, Alexander S [VerfasserIn]
Gelman, Andrew E [VerfasserIn]
Kreisel, Daniel [VerfasserIn]

Links:

Volltext

Themen:

Cell death
Damage-associated molecular patterns
Graft rejection
Innate immunity
Journal Article
Lung transplantation
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review

Anmerkungen:

Date Completed 31.01.2022

Date Revised 31.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.healun.2021.03.017

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM325702055